In the annual filings, revenue rose from KRW 46 billion in 2022 to KRW 58.7 billion in 2023 (up 27.7% year on year), KRW 68.5 billion in 2024 (up 16.7%), and KRW 76.9 billion in 2025 (up 12.2%). Revenue has increased for three consecutive years from 2023 through 2025.
Operating profit moved in both directions over the same period: KRW 4.01 billion in 2022, KRW 2.63 billion in 2023 (down 34.3%), KRW 4.11 billion in 2024 (up 56.1%), and KRW 3.82 billion in 2025 (down 7.1%).
The operating margin fell from 8.7% in 2022 to 4.5% in 2023, then recovered to 6.0% in 2024 and 5.0% in 2025, still below the 2022 level. The company attributed the 2025 operating profit decline to a temporary rise in expenses, and cited growth in global filler sales as the driver of higher revenue.
Net income attributable to controlling shareholders reached KRW 14 billion in 2023, but turned to a net loss of KRW 188 million in 2024 and widened to a net loss of KRW 6.6 billion in 2025.
Net income including non-controlling interests was a loss of KRW 2.61 billion in 2024 and KRW 7.44 billion in 2025, two consecutive years of losses. The company explained the 2025 net loss widening with lower tax benefits from deferred tax changes.
Operating cash flow fell from KRW 14.2 billion in 2022 to KRW 3.72 billion in 2024 before recovering to KRW 11.1 billion in 2025.
In quarterly filings, the third quarter of 2025 showed revenue of KRW 20.1 billion and operating profit of KRW 1.02 billion, while the first quarter of 2026 swung to revenue of KRW 16 billion and an operating loss of KRW 665 million.
The second quarter of 2026 returned to operating profit of KRW 2.31 billion on revenue of KRW 20.1 billion. Third-quarter revenue of KRW 18.9 billion fell 6.1% year on year, while operating profit of KRW 1.42 billion rose 39.2%.
The net loss attributable to controlling shareholders in the third quarter of 2026 was KRW 3.81 billion, a wider loss than a year earlier.